Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|18|2|155-162
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.2, 2018-02, pp. : 155-162
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Medications and Glucose-6-Phosphate Dehydrogenase Deficiency: An Evidence-Based Review
Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. :
Glucose-6-Phosphate Dehydrogenase Deficiency and Safety of Methylene Blue
By Müller Olaf
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :
Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 3, 2014-12 ,pp. :